Actively Recruiting
Gestational Diabetes
Led by University Hospital Tuebingen · Updated on 2022-08-22
800
Participants Needed
1
Research Sites
831 weeks
Total Duration
On this page
Sponsors
U
University Hospital Tuebingen
Lead Sponsor
D
Deutsches Diabeteszentrum (DDZ), Leibniz-Institut Düsseldorf
Collaborating Sponsor
AI-Summary
What this Trial Is About
Due to a changed lifestyle with less physical activity, unfavorable diets rich in fat and calories and obesity, the prevalence of diabetes mellitus is increasing worldwide. The diabetes epidemic is associated with significant personal and socio-economic consequences. Despite attempts to prevent the complications of diabetes, this disease is still the leading cause of blindness, chronic renal insufficiency and non-traumatic amputation. It is important to detect early on an increase in blood sugar and treat it accordingly to reduce costs and to minimize the personal suffering of those affected. As the number of patients with type 2 diabetes mellitus continues to rise, the number of young women with gestational diabetes mellitus (GDM) also increases. This is a disorder og glucose metabolism, which occurs for the first time in pregnancy. The causes for this are manifold. Among other causes, the increasing age of the mothers and weight gain during pregnancy are risk factors for gestational diabetes. Although it has been recommended that women with gestational diabetes should be re-examined after the birth of their child, many women have not. The study is a follow-up study to clarify whether insulin secretion disorder in women with and after GDM is a risk factor for the occurrence of type 2 diabetes mellitus.
CONDITIONS
Official Title
Gestational Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed and dated informed consent
- Enrollment possible during pregnancy between gestational week 24+0 and 31+6
- Enrollment possible postpartum if gestational diabetes was documented in previous pregnancy
You will not qualify if you...
- Under 18 years of age
- Diagnosed with type 1 or type 2 diabetes mellitus
- Glomerular filtration rate (GFR) less than 60 ml/min/1.73 m2
- C-reactive protein (CRP) greater than 1 mg/dl
- Transaminase levels more than twice the upper limit of normal
- Preexisting heart conditions
- Weight loss greater than 10% within 6 months before joining
- Psychiatric disorders
- Chronic alcohol or substance abuse
- Use of drugs that increase or decrease blood sugar such as steroids, antidiabetics, or insulin
- For postpartum visits only: currently pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tuebingen
Tübingen, Germany, 72076
Actively Recruiting
Research Team
A
Andreas Fritsche, MD
CONTACT
L
Louise Fritsche, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here